Journal of Biomedical Science and Engineering

ISSN Print: 1937-6871    ISSN Online: 1937-688X

Call For Papers

    Special Issue on Biosimilars 


    A Biosimilar product is a biological product that is approved based on a showing that it is highly similar to an FDA-approved biological product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products.


    In this special issue, we intend to invite front-line researchers and authors to submit original researches and review articles on exploring Biosimilars. Potential topics include, but are not limited to:


    • Generic drugs
    • Biosimilars approval process
    • Differences with chemical generic drugs
    • Bioequivalence
    • Pharmacovigilance
    • Biological analogues
    • Development prospects of biosimilars

                         

    Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.    


    Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue – Biosimilars” should be chosen during your submission.


    According to the following timetable:


    Submission Deadline

    December 19th, 2017

    Publication Date

     February 2018


    Guest Editor:


    For further questions or inquiries

    Please contact Editorial Assistant at

    jbise@scirp.org